New targets and epitopes to bind, more ways to fight, more patients to help.

Sanavia Oncology Inc. is a venture-backed, New York-based, next generation biotech company, founded by scientists and clinicians from Rockefeller University, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, Columbia University and pharma veterans from Amgen, Genentech, Roche and Gilead.